In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Capricor Therapeutics Inc.

www.capricor.com

Latest From Capricor Therapeutics Inc.

Capricor’s Interim Data Could Offer Hope For Older DMD Patients

Although only interim data from six treated patients, Capricor’s Phase II DMD study shows improvements in upper limb performance, grip strength and respiration. Cardiac performance shows positive trend, but not yet statistical significance.

Clinical Trials Rare Diseases

Finance Watch: Gossamer, Alector And Harpoon Launch First Biopharma IPOs Of 2019

Public Company Edition: Grossing $276m, Gossamer would have been the third-largest biopharma IPO in the US if it had launched last year. Also, recent public company financings include debt and follow-on offerings; and two more firms cut jobs – Capricor and Seres.

Financing Business Strategies

Pipeline Watch: Phase III Progress With Keytruda, Bempedoic Acid And Ubrogepant

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

 

Approvals Pipeline Watch

Keeping Track: DMD, RMAT, HIV, BTDs, Tc-99m – FTW

The latest drug development news and highlights from our US FDA Performance Tracker.

Drug Review Regulation
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Capricor Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Capricor Therapeutics Inc.
  • Senior Management
  • Linda S Marban, PhD, Pres. & CEO
    Leland Gershell, MD, PhD, CFO
    Rachel Smith, PhD, VP, R&D
    Deborah Ascheim, MD, CMO
  • Contact Info
  • Capricor Therapeutics Inc.
    Phone: (310) 358-3200
    8840 Wilshire Blvd., 2nd Fl.
    Beverly Hills, CA 90211
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register